SCHEMBL7708451

SCHEMBL7708451

Nc1ncc(OCc2ccc(Cl)cc2)c(N2CCN(CCO)CC2)n1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.43
ROCK1 Q13464 2/20 0.43
HRH4 Q9H3N8 1/20 0.43
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SRC P12931 1/20 0.40
HTR2A P28223 1/20 0.39
DHFR P00374 1/20 0.39
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39
HRH1 P35367 1/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
METAP1 P53582 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7714283 0.86 HRH4 (0.57) HRH4
SCHEMBL7708442 0.86 LMNA (0.45) ROCK2ROCK1HRH4ALDH1A1HPGD
SCHEMBL7708553 0.84 DHFR (0.42) ROCK2ROCK1HRH4ALDH1A1HPGD
SCHEMBL7714413 0.82 ROCK2 (0.44) ROCK2ROCK1HRH4ALDH1A1HPGD
SCHEMBL7714412 0.82 MGMT (0.46) ALDH1A1HSD17B10DHFR
SCHEMBL7712408 0.81 ROCK2 (0.43) ROCK2ROCK1HRH4ALDH1A1HPGD
SCHEMBL7708465 0.81 HTR7 (0.43) ROCK2ROCK1HRH4ALDH1A1HPGD
SCHEMBL7708469 0.81 ROCK2 (0.49) ROCK2ROCK1HRH4ALDH1A1HPGD
SCHEMBL7708476 0.79 ROCK2 (0.40) ROCK2ROCK1HRH4ALDH1A1METAP1
SCHEMBL7712407 0.79 HTR1A (0.46) ROCK2ROCK1HRH4ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed